Recherche
Résultats 1-8 de 8
-
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (t-dis): a randomised phase 2 trial
The Lancet. Oncology, 01-03-2015, 16, 312-319Article dans une revue scientifique -
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (lms-02): a non-randomised, multicentre, phase 2 trial
The Lancet. Oncology, 01-04-2015, 16, 457-464Article dans une revue scientifique -
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet. Oncology, 01-05-2015, 16, 531-540Article dans une revue scientifique -
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (os2006): a randomised, multicentre, open-label, phase 3 trial
The Lancet. Oncology, 01-08-2016, 17, 1070-1080Article dans une revue scientifique -
Personalised management of alveolar soft part sarcoma: a promising phase 2 study
The Lancet. Oncology, 08-05-2019Article dans une revue scientifique -
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
The Lancet. Oncology, 20-03-2018Article dans une revue scientifique -
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (regosarc): a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet. Oncology, 01-12-2016, 17, 1732-1742Article dans une revue scientifique -
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
The Lancet. Oncology, Elsevier, 23-11-2018, 20 (1), 120-133Article dans une revue scientifique